Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
THORATEC CORP (THOR) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/08/2015 8-K Quarterly results
10/08/2015 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Articles of Incorporation of Thoratec Corporation",
"Amended and Restated Bylaws of Thoratec Corporation"
10/01/2015 8-K Other Events
08/31/2015 8-K Other Events
08/04/2015 8-K Quarterly results
Docs: "Exhibit 99.1 Thoratec® Reports Second Quarter 2015 Results"
07/22/2015 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger, by and among Thoratec Corporation, SJM International, Inc., Spyder Merger Corporation and St. Jude Medical, Inc",
"Third Amended and Restated By-laws, as amended on July 21, 2015",
"Form of Gross-Up Payment letter agreement",
"Voting Agreement, by and among SJM International, Inc., Spyder Merger Corporation and certain holders of shares and other equity interests of Thoratec Corporation",
"St. Jude Medical and Thoratec Announce Definitive Agreement"
05/08/2015 8-K Submission of Matters to a Vote of Security Holders
05/07/2015 8-K Quarterly results
Docs: "Thoratec® Reports First Quarter 2015 Results"
04/27/2015 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Third Amended and Restated Bylaws of Thoratec Corporation, as amended and restated on April 27, 2015",
"Third Amended and Restated Bylaws of Thoratec Corporation, as amended and restated on April 27, 2015, marked to show all changes"
04/08/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
02/10/2015 8-K Quarterly results
Docs: "Fourth Quarter and Fiscal Year 2014 Financial Results"
11/05/2014 8-K Quarterly results
Docs: "Third Quarter and First Nine Months of 2014 Financial Results"
10/06/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "THORATEC ANNOUNCES ADDITIONS TO SENIOR MANAGEMENT TEAM"
09/22/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Second Amended and Restated Bylaws of Thoratec Corporation, as amended and restated on September 16, 2014",
"Employment Agreement, with D. Keith Grossman",
"Transition and Separation Agreement, with Gary F. Burbach",
"THORATEC APPOINTS D. KEITH GROSSMAN PRESIDENT AND CHIEF EXECUTIVE OFFICER COMPANY PROVIDES THIRD QUARTER FINANCIAL UPDATES"
08/06/2014 8-K Quarterly results
Docs: "Second Quarter and First Six Months of 2014 Financial Results"
07/02/2014 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "EQUITY PURCHASE AGREEMENT dated as of by and among THORATEC SWITZERLAND GmbH, APICA CARDIOVASCULAR LIMITED, The SELLERS listed on Schedule I hereto, SEROBA KERNEL LIFE SCIENCES LIMITED, as the Sellers' Representative, and solely for the purposes set forth in Section 11.16 , THORATEC CORPORATION, relating to the purchase and sale of certain outstanding equity interests of APICA CARDIOVASCULAR LIMITED **",
"The Party named in the Schedule Thoratec Switzerland Gmbh Thoratec Corporation SHARE PURCHASE AGREEMENT McCann FitzGerald Solicitors Riverside One Sir John Rogerson's Quay Dublin 2 THIS AGREEMENT is made on 2 July 2014 BETWEEN THE PARTY NAMED IN THE SCHEDULE ; THORATEC SWITZERLAND GMBH, a Swiss corporation ; and THORATEC CORPORATION , a California corporation . RECITALS: Apica Cardiovascular Limited is a private limited company incorporated in Ireland under the Companies Acts 1963 to 2013 on 22 October 2010 under number 490553 and having an authorised share capital of €200,000 divided into 10,000,000 Series A Shares of €0.01 each and 10,000,000 Ordinary Shares of €0.01 each. The Seller is the legal and beneficial owner of 26,280 Series A Shares in the capital of the Company . The Seller ha...",
"THORATEC ACQUIRES APICA CARDIOVASCULAR"
05/27/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/06/2014 8-K Quarterly results
Docs: "Thoratec® Reports First Quarter 2014 Results"
03/27/2014 8-K Regulation FD Disclosure
03/17/2014 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/04/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "For Immediate Release — March 4, 2014 Thoratec Contacts: Technical - Donald A. Middlebrook, 730-4117 General — 528-2577 Web site: http://www.thoratec.com Thoratec Corporation Issues Worldwide Urgent Medical Device Correction Letter to Update its Labeling Regarding the Use of the HeartMate II® LVAS Pocket System Controller PLEASANTON, California — On March 4, 2014, Thoratec Corporation initiated a voluntary worldwide Medical Device Correction in order to update its labeling and training materials for the HeartMate II® LVAS Pocket System Controller . This safety advisory is being issued because some patients and caregivers have experienced difficulties with the process of changing from a primary system controller to their backup system controller. These difficulties have resulted in four dea..."
02/04/2014 8-K Quarterly results
Docs: "About Thoratec"
10/30/2013 8-K Form 8-K - Current report
07/31/2013 8-K Quarterly results
Docs: "About Thoratec"
07/01/2013 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State...
Docs: "Asset Purchase Agreement, by and among Thoratec Corporation, Terumo Corporation and Terumo Heart, Inc"
05/02/2013 8-K Quarterly results
Docs: "Thoratec® Reports First Quarter 2013 Results - Revenue of $117.7 million for the first quarter of 2013 - GAAP Net Income per Diluted Share of $0.31, and Non-GAAP Net Income per Diluted Share of $0.41"
03/08/2013 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/01/2012 8-K Quarterly results
Docs: "Third Quarter and First Nine Months of 2012 Financial Results"
10/11/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "THORATEC APPOINTS TAYLOR C. HARRIS AS CHIEF FINANCIAL OFFICER , October 11, 2012—Thoratec Corporation , a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that its Board of Directors has appointed Taylor C. Harris to the position of Vice President and Chief Financial Officer. Mr. Harris joined Thoratec in 2010 as Senior Director of Investor Relations and Business Development. Prior to joining Thoratec, Mr. Harris worked at JPMorgan Chase & Co. for over a decade in several capacities, including as a Vice President in the firm's Healthcare Investment Banking and Equity Research departments. In these roles, Mr. Harris covered the medical device sector as an investment research analyst and advised healthcare comp..."
08/01/2012 8-K Quarterly results
Docs: "Second Quarter and First Half of 2012 Financial Results"
05/29/2012 8-K Form 8-K - Current report
05/01/2012 8-K Quarterly results
Docs: "FINANCIAL HIGHLIGHTS"
03/09/2012 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/25/2012 8-K Other Events
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy